329
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clonal Expansions of Cd8 + T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Clonal composition and T cell receptor (TCR) repertoire of CD4 + and CD8 + T cells infiltrating actively demyelinating multiple sclerosis (MS) lesions were determined with unprecedented resolution at the level of single cells. Individual CD4 + or CD8 + T cells were isolated from frozen sections of lesional tissue by micromanipulation and subjected to single target amplification of TCR-β gene rearrangements. This strategy allows the assignment of a TCR variable region (V region) sequence to the particular T cell from which it was amplified. Sequence analysis revealed that in both cases investigated, the majority of CD8 + T cells belonged to few clones. One of these clones accounted for 35% of CD8 + T cells in case 1. V region sequence comparison revealed signs of selection for common peptide specificities for some of the CD8 + T cells in case 1. In both cases, the CD4 + T cell population was more heterogeneous. Most CD4 + and CD8 + clones were represented in perivascular infiltrates as well as among parenchymal T cells. In case 2, two of the CD8 + clones identified in brain tissue were also detected in peripheral blood. Investigation of the antigenic specificities of expanded clones may help to elucidate their functional properties.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: found
          • Article: not found

          HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

          In most PCR-based tissue typing techniques the PCR amplification is followed by a post-amplification specificity step. In typing by PCR amplification with sequence-specific primers (PCR-SSP), typing specificity is part of the amplification step, which makes the technique almost as fast as serological tissue typing. In the present study primers were designed for DR "low-resolution" typing by PCR-SSP, i.e. identifying polymorphism corresponding to the serologically defined series DR1-DRw18. This resolution was achieved by performing 19 PCR reactions per individual, 17 for assigning DR1-DRw18 and 2 for the DRw52 and DRw53 superspecificities. Thirty cell lines and 121 individuals were typed by the DR "low-resolution" PCR-SSP technique, TaqI DRB-DQA-DQB RFLP analysis and serology. The concordance between PCR-SSP typing and RFLP analysis was 100%. The reproducibility was 100% in 40 samples typed on two separate occasions. No false-positive or false-negative typing results were obtained. All homozygous and heterozygous combinations of DR1-DRw18 could be distinguished. Amplification patterns segregated according to dominant Mendelian inheritance. DNA preparation, PCR amplification and post-amplification processing, including gel detection, documentation and interpretation, were performed in 2 hours. In conclusion, PCR-SSP is an accurate typing technique with high sensitivity, specificity and reproducibility. The method is rapid and inexpensive. DR "low-resolution" typing by the PCR-SSP technique is ideally suited for analyzing small numbers of samples simultaneously and is an alternative to serological DR typing in routine clinical practice including donor-recipient matching in cadaveric transplantations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Identification of autoantibodies associated with myelin damage in multiple sclerosis.

            The molecular mechanisms underlying myelin sheath destruction in multiple sclerosis lesions remain unresolved. With immunogold-labeled peptides of myelin antigens and high-resolution microscopy, techniques that can detect antigen-specific antibodies in situ, we have identified autoantibodies specific for the central nervous system myelin antigen myelin/oligodendrocyte glycoprotein. These autoantibodies were specifically bound to disintegrating myelin around axons in lesions of acute multiple sclerosis and the marmoset model of allergic encephalomyelitis. These findings represent direct evidence that autoantibodies against a specific myelin protein mediate target membrane damage in central nervous system demyelinating disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Monocyte/macrophage differentiation in early multiple sclerosis lesions.

              Monocyte/macrophage differentiation was studied in biopsy samples of multiple sclerosis (MS) lesions obtained in the early course of the disease. Macrophages were identified by immunocytochemistry using a panel of antibodies recognizing different macrophage-activation antigens. The number of cells stained with each antibody was related to the demyelinating activity of the lesions as detected by the presence of myelin degradation products. The pan-macrophage marker Ki-M1P revealed the highest numbers of macrophages in early and late active lesions. Lower numbers were encountered in inactive, demyelinated, or remyelinated lesions. The acute stage inflammatory macrophage markers MRP14 and 27E10 were expressed in either only early active (MRP14) or early and late active (27E10) lesions, thus allowing the identification of actively demyelinating lesions. The chronic stage inflammatory macrophage marker 25F9, in contrast, showed increasing expression with decreasing lesional activity. These findings indicate a differentiated pattern of macrophage activation in MS lesions and allow the staging of demyelinating lesions in routinely fixed and paraffin-embedded tissue.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                7 August 2000
                : 192
                : 3
                : 393-404
                Affiliations
                [a ]Institute for Genetics, Institute for Pathology, University of Cologne, 50931 Cologne, Germany
                [b ]Department of Neuropathology, Institute for Pathology, University of Cologne, 50931 Cologne, Germany
                [c ]Department of Neuroimmunology, Brain Research Institute, University of Vienna, 1090 Vienna, Austria
                [d ]Department of Neuroimmunology, Max-Planck-Institute for Neurobiology, 82152 Martinsried, Germany
                [e ]Department of Neuropathology, University of Bonn, 53105 Bonn, Germany
                [f ]Department of Neurology, University of Bonn, 53105 Bonn, Germany
                [g ]Netherlands Brain Bank, 1105 AZ Amsterdam, The Netherlands
                Article
                000444
                10.1084/jem.192.3.393
                2193223
                10934227
                2a3617b6-4009-4dda-aa20-f6019f76ef7a
                © 2000 The Rockefeller University Press
                History
                : 15 March 2000
                : 9 May 2000
                : 18 May 2000
                Categories
                Original Article

                Medicine
                gene rearrangement,autoimmunity,demyelinating disease,t cell receptor β chain,peripheral blood

                Comments

                Comment on this article